Large-cap Health Care company Sanofi ADS has moved -0.0% so far today on a volume of 223,199, compared to its average of 3,238,407. In contrast, the S&P 500 index moved 1.0%.
Sanofi ADS trades -14.87% away from its average analyst target price of $60.63 per share. The 9 analysts following the stock have set target prices ranging from $53.0 to $69.0, and on average have given Sanofi ADS a rating of buy.
If you are considering an investment in SNY, you'll want to know the following:
-
Sanofi ADS's current price is -34.1% below its Graham number of $78.38, which implies the stock has a margin of safety
-
Sanofi ADS has moved -5.0% over the last year, and the S&P 500 logged a change of 16.6%
-
Based on its trailing earnings per share of 3.04, Sanofi ADS has a trailing 12 month Price to Earnings (P/E) ratio of 17.0 while the S&P 500 average is 29.3
-
SNY has a forward P/E ratio of 10.4 based on its forward 12 month price to earnings (EPS) of $4.94 per share
-
Its Price to Book (P/B) ratio is 0.86 compared to its sector average of 3.19
-
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions.
-
Based in Paris, the company has 82,878 full time employees and a market cap of $125.75 Billion.
